← Danone SA overview

Danone SA vs Thai Coconut: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Danone SA (BN.PA)

Q3 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

July 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

Latest
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

Thai Coconut Public Company Limited (COCOCO.BK)

Q3 2026
▲3▼1

COCOCO: profit surge and Philippine plant offset US tariff drag

  • US 12.5% tariff on Thai goods pressures exports The US imposed a 12.5% tariff on Thai imports, and COCOCO earns about 19% of revenue from the US. That makes its coconut products more expensive there and can slow orders. The hit is softened because buyers already absorbed a bigger 19% tariff before, and the new Philippine factory will soon make goods for the US from a country with a better tax deal.

    This is the main force pushing COCOCO's price down this period.

  • Q2 and first-half profit jump on lower coconut costs COCOCO's second-quarter profit rose 58.5% from a year earlier to 122.6 million baht, and first-half profit climbed 44% to 205 million baht. The gain came from strong coconut milk and pet food sales in the US and Europe, cheaper coconuts, and better pricing. Higher profit makes the stock more attractive and supports the price.

    Strong earnings are the biggest positive driver for the stock.

  • Yuanta keeps Buy and 8 baht target, sees 142.6% profit jump Yuanta Securities maintained its Buy rating and 8.00 baht fair value, expecting 2026 profit to surge 142.6% to 544 million baht. It cited the export high season, a heatwave boosting drink demand, full 7-Eleven sales, and falling coconut costs. A broker's strong outlook often pulls buyers in and lifts the price.

    Analyst backing gives a clear positive signal for the stock.

  • Philippine plant to cut costs and open Europe, US deals COCOCO is building a factory in the Philippines, set to start production by early 2027. Philippine coconuts cost about 20% less than Thai ones, and the plant can sell to Europe under a free trade deal. It also helps avoid US tariffs. This long-term plan supports the stock by promising cheaper output and more customers.

    The new plant is a key structural positive that offsets tariff risk.

August 2026
▲3▼1

COCOCO: profit surge and Philippine plant offset US tariff drag

  • US 12.5% tariff on Thai goods pressures exports The US imposed a 12.5% tariff on Thai imports, and COCOCO earns about 19% of revenue from the US. That makes its coconut products more expensive there and can slow orders. The hit is softened because buyers already absorbed a bigger 19% tariff before, and the new Philippine factory will soon make goods for the US from a country with a better tax deal.

    This is the main force pushing COCOCO's price down this period.

  • Q2 and first-half profit jump on lower coconut costs COCOCO's second-quarter profit rose 58.5% from a year earlier to 122.6 million baht, and first-half profit climbed 44% to 205 million baht. The gain came from strong coconut milk and pet food sales in the US and Europe, cheaper coconuts, and better pricing. Higher profit makes the stock more attractive and supports the price.

    Strong earnings are the biggest positive driver for the stock.

  • Yuanta keeps Buy and 8 baht target, sees 142.6% profit jump Yuanta Securities maintained its Buy rating and 8.00 baht fair value, expecting 2026 profit to surge 142.6% to 544 million baht. It cited the export high season, a heatwave boosting drink demand, full 7-Eleven sales, and falling coconut costs. A broker's strong outlook often pulls buyers in and lifts the price.

    Analyst backing gives a clear positive signal for the stock.

  • Philippine plant to cut costs and open Europe, US deals COCOCO is building a factory in the Philippines, set to start production by early 2027. Philippine coconuts cost about 20% less than Thai ones, and the plant can sell to Europe under a free trade deal. It also helps avoid US tariffs. This long-term plan supports the stock by promising cheaper output and more customers.

    The new plant is a key structural positive that offsets tariff risk.

Latest
▲3▼1

COCOCO: profit surge and Philippine plant offset US tariff drag

  • US 12.5% tariff on Thai goods pressures exports The US imposed a 12.5% tariff on Thai imports, and COCOCO earns about 19% of revenue from the US. That makes its coconut products more expensive there and can slow orders. The hit is softened because buyers already absorbed a bigger 19% tariff before, and the new Philippine factory will soon make goods for the US from a country with a better tax deal.

    This is the main force pushing COCOCO's price down this period.

  • Q2 and first-half profit jump on lower coconut costs COCOCO's second-quarter profit rose 58.5% from a year earlier to 122.6 million baht, and first-half profit climbed 44% to 205 million baht. The gain came from strong coconut milk and pet food sales in the US and Europe, cheaper coconuts, and better pricing. Higher profit makes the stock more attractive and supports the price.

    Strong earnings are the biggest positive driver for the stock.

  • Yuanta keeps Buy and 8 baht target, sees 142.6% profit jump Yuanta Securities maintained its Buy rating and 8.00 baht fair value, expecting 2026 profit to surge 142.6% to 544 million baht. It cited the export high season, a heatwave boosting drink demand, full 7-Eleven sales, and falling coconut costs. A broker's strong outlook often pulls buyers in and lifts the price.

    Analyst backing gives a clear positive signal for the stock.

  • Philippine plant to cut costs and open Europe, US deals COCOCO is building a factory in the Philippines, set to start production by early 2027. Philippine coconuts cost about 20% less than Thai ones, and the plant can sell to Europe under a free trade deal. It also helps avoid US tariffs. This long-term plan supports the stock by promising cheaper output and more customers.

    The new plant is a key structural positive that offsets tariff risk.